Deepak Fertilisers & Petrochemicals Corporation Ltd held its 46th AGM, reporting a robust start to FY27 with a 101% jump in Q1 PAT to Rs 490 Cr. The company is nearing completion of major capex projects in Gopalpur and Dahej, which are set to commission in H2 FY27. Management highlighted improved leverage, with the Net Debt/EBITDA ratio dropping to 1.40x. Investors should track the operational commencement of these high-capacity expansion projects as they transition to long-term revenue contributors.
Deepak Fertilisers AGM: Q1 Profit Doubles as Major Projects Nears Completion
Q1 FY27 Profit After Tax reached Rs 490 Cr, up 101% year-on-year.
Capex projects at Gopalpur and Dahej are 96% and 93% complete respectively.
Reader Takeaway: Strong operational turnaround and improved leverage; monitor H2 FY27 project commissioning for sustained growth momentum.
What just happened
Deepak Fertilisers & Petrochemicals Corporation Ltd held its 46th Annual General Meeting on September 1, 2026. The management provided a comprehensive update on the company’s strong start to the new fiscal year and progress on critical infrastructure investments. Significant board changes were also confirmed, with the induction of Dr. Purvi Mehta Bhatt and Mr. Yeshil Sailesh Mehta.
Why this matters
The company’s strategic shift toward high-value products and backward integration is delivering results. Despite FY26 being a year of cyclical headwinds, Q1 FY27 revenue rose by 22% to Rs 3,256 Cr. Most importantly, the company significantly improved its balance sheet health, reducing net debt to Rs 4,719 Cr and bringing the Net Debt/EBITDA ratio down to 1.40x from 2.86x just three months prior.
Capex and Expansion
Two major projects remain the centerpiece of the company's growth strategy. The Gopalpur TAN project is 96% complete and will elevate the firm to the world's 3rd largest pure-play TAN producer. The Dahej Nitric Acid expansion is 93% complete and will establish the company as Asia's largest Nitric Acid manufacturer. Both projects, representing a Rs 4,650 Cr outlay, are slated for commissioning in H2 FY27.
Risks to watch
While the company has shown resilience, investors should note that the capital-intensive nature of the current growth cycle requires tight execution. Any delays in commissioning the Gopalpur or Dahej facilities could defer expected revenue contributions to the P&L. Furthermore, the company remains subject to global gas price volatility and geopolitical supply chain risks that impacted FY26 performance.
What to track next
The primary focus for investors is the H2 FY27 commissioning timeline. Full operational capacity is expected to show significant contributions in the next financial year, providing a potential tailwind for margins and market dominance in the TAN and Nitric Acid segments.